Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials

PURPOSE: Patients with advanced hepatocellular carcinoma (HCC) have limited effective therapeutic options. Given the rapid advanced in drug development and emergence of novel agents, we analyzed the characteristics and outcomes of HCC patients treated on early phase trials with an emphasis on target...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Subbiah, Ishwaria M., Falchook, Gerald S., Kaseb, Ahmed O., Hess, Kenneth R., Tsimberidou, Apostolia M., Fu, Siqing, Subbiah, Vivek, Hong, David S., Naing, Aung, Sarina, A. Piha-Paul, Akmal, Owais, Janku, Filip, Kurzrock, Razelle
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2015
Soggetti:
Clinical Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695071/
https://ncbi.nlm.nih.gov/pubmed/26164085
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi